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INTRODUCTION
It has been reported that in a substantial population of sporadic cases of hormone-dependent cancers in the mammary and prostate glands of humans, the tumor is generated under the influence of yet-unidentified heritable factors.
1) The delineation of these factors associated with tumor susceptibility as well as non-heritable (or environmental) factors involved in tumor etiology is essential for the effective prevention and treatment of breast cancers.
2) Brca1 and Brca2, which have so far been identified as mammary tumor susceptibility genes, account for approximately 40% of the familial breast cancer cases.
3) Unlike Brca1 and Brca2 with a relatively higher penetrance, the genes responsible for tumor susceptibility are frequently expressed with low penetrance among cancers referred to as sporadic. Tumor susceptibility, therefore, seems to be difficult to analyze using human populations whose genetic composition is intrinsically heterogeneous. To investigate such weak and multi-factorial traits as tumor susceptibility, animal models with genetic homogeneity may be useful.
Among inbred strains of mice, the BALB/c mouse is susceptible to radiation-induction of mammary tumors, while the C57BL/6 mouse is resistant. 4) This suggests the presence of hereditary factors influencing tumorigenesis in the mammary grand. As reported previously, however, mammary tumors develop with a low frequency and a long latency (normally more than 1 year), both of which are common features of solid tumors. 4, 5) For successful analysis, these problems must be resolved.
When irradiated with ionizing radiation, p53 hemizygous (+/-) mice can develop tumors at an extremely high frequency and short latency compared to p53 wild-type (+/+) animals. 6) Exploiting the tumor-promoting potential of the p53 deficiency, it might be possible to facilitate tumorigenesis in the mammary gland of BALB/c mice exposed to radiation. It has been reported that mice bearing the p53 deficient allele are, unfortunately, highly predisposed to lymphomas, compromising the utility of the p53 +/-mouse as an animal model for the study of solid tumors. 7) To begin with, therefore, we examined the effects of the p53 deficient allele and ionizing radiation on the tumor spectrum of BALB/c mice.
In the present study, we showed a preferential induction of mammary tumors with fractionated X-irradiation in BALB/c mice bearing the p53 deficient allele, thereby providing a useful experimental system for the study of mammary tumor susceptibility.
MATERIALS AND METHODS

Animals
The p53 deficient allele originally created by Donehower et al. 7) was introduced into the BALB/cHeA mouse at The Netherlands Cancer Institute (Amsterdam). The p53 hemizygous (+/-) progeny were backcrossed repeatedly to BALB/cHeA (BALB/ c) and maintained as BALB/c-p53 +/-mice at the animal facility of Osaka Prefecture University (Osaka), as described elsewhere. 8) BALB/c-p53 +/+, +/-and -/-mice used were produced by intercrossing p53 +/-siblings from p53 +/-parents at the 10th to 15th backcross with BALB/c or by backcrossing the siblings with BALB/c mice.
X-irradiation
X-irradiation was performed with an X-ray generator Radioflex 350 (Rigaku Industrial Corp., Takatsuki) operated at 260 kVp, 12.0 mV and a dose rate of 0.46 Gy/min with a filter (0.3 mm Cu plus 0.5 mm Al). Five to 8-week-old animals with or without the p53 deficient allele were subjected to 4 Gy of irradiation (p53 +/-genotype, 44 females and 19 males; p53 +/+ genotype, 31 females and 18 males). Four to 5-week-old female animals with or without the p53 deficient allele were 4-times irradiated with 0.7 Gy of X-rays at weekly intervals (p53 +/-, 23 animals; p53 +/+, 26 animals).
Pathological examination
Mice bearing tumors were killed for anatomical examination, and affected organs were autopsied and fixed in 10% buffered formalin to be processed for histology. Tissue specimens were stained with hematoxilin and eosin. Tumor types were determined both by anatomical and by histological examinations.
Genotyping of p53 and LOH analysis
Template DNAs were isolated from tails and tumors as described.
9) The genotype of the p53 gene and loss of heterozygosity at the p53 gene in the tumors generated in p53 +/-mice were analyzed by PCR, followed by agarose electrophoresis as described. 8) Briefly, PCR was performed using primers 5′-CGACCTCCGTTCTCTCTCCTCTCTT-3′ (forward) derived from intron 4,5′-AGACGCACAAACCAAAACAAAATTACA-3′ (reverse) derived from intron 6 of the p53 gene and 5′-GCCTTCTATCGCCTTCTTGACGAGT-3′ (forward) derived from the neo-cassette according to a program consisting of 1 cycle of 94°C for 3 min, 35 cycles of 94°C for 75 s, 62°C for 1 min and 72°C for 75 s, and 1 cycle of 72°C for 3 min and 30°C for 1 min. PCR products were electrophoresed in 2% agarose gels. DNA bands were visualized by UV irradiation after staining with ethidium bromide. Heterozygous cases with obviously reduced intensity of DNA bands for the p53 wild-type allele in the tumors were scored as having an allelic imbalance (AI).
RESULTS
The effects of the p53 deficient allele and of 4 Gy X-irradiation on the tumor spectrum
We first examined the type and frequency of tumors arising spontaneously in BALB/c-p53 -/-, +/-and +/+ mice ( Table 1) . Except for one female with no visible tumors at necropsy, 6/7 (86%) females and 13/13 (100%) males with the p53 -/-genotype died of a single type of tumor, i.e., thymic lymphoma, before 36 weeks of age. At this age, mortalities of the p53 +/-females and males were 5% (1/22) and 11% (1/9), respectively, being each due to non-thymic lymphoma and histiocytic sarcoma. Neither p53 +/+ females nor males died before 36 weeks of age. When observation was extended to 52 weeks of age, mortality of the p53 +/-females rose to 14% (3/22), due to mammary adenocarcinoma and unknown cause in addition to lymphoma, which occurred before 36 weeks of age, while mortality of p53 +/-males remained unchanged (data not shown). During the period, no death was observed in p53 +/+ females as well as males (data not shown).
To test the effects of a single sub-lethal dose of X-irradiation and the p53genotype on the tumor spectrum, p53 +/-and +/+ mice at 5-8 weeks of age were subjected to 4 Gy of X-irradiation. The results are presented in Table 2 . Most of the irradiated p53 +/-mice died of tumors within 36 weeks following irradiation with mortality rates of 100% (44/44) and 95% (18/19) in females and males, respectively. Among these, 26/44 (59%) females and 13/19 (68%) males died of lymphomas, indicating that the dominant type of tumor was lymphoma. Notably, 21/26 (81%) and 12/13 (92%) of lymphomas developed in the p53 +/-females and males, respectively, were thymic lymphomas; the rest were non-thymic lymphomas involving spleen and lymph nodes, but with atrophic thymus. The semi-dominant cause of death in the p53 +/-females was mammary adenocarcinomas, generated with a considerable frequency of 15/44 (34%). Various types of soft-tissue and bone sarcomas were occasionally generated at lower incidences of 2/44 (5%) and 3/19 (14%) in p53 +/-females and males, respectively. At necropsy, tumor multiplicity was observed in the p53 +/-mice bearing mammary tumors: in 5 (33%) of 15 animals, more than one primary tumor were detected in the mammary gland, and in another 5, lymphomas and/or soft-tissue sarcomas were generated. During the same period, similarly treated p53 +/+ animals also died, giving mortalities of 16% (5/31) and 17% (3/18) in females and males, respectively. Most, if not all, of the deaths were due to thymic lymphomas.
Preferential induction of mammary tumors with 4 × 0.7 Gy of X-irradiation in p53 +/-female mice
Four gray of X-irradiation were effective in the induction of mammary tumors in BALB/c-p53 +/-animals. However, the death of animals bearing lymphomas, in particular, of the thymic type, may possibly mask the manifestation of potential mammary tumors in 4 Gy-irradiated p53 +/-animals. To test whether the rate of lymphomas was cut down by the use of a reduced Xray dose, p53 +/-and +/+ females were irradiated with 2.8 Gy, a 30% reduced dose, of X-rays, according to a fractionated irradiation protocol, i.e., animals at 4-5 weeks of age were irradiated 4 times with 0.7 Gy (4 × 0.7 Gy) at weekly intervals. The results are presented in Table 3 . Of 23 animals with the p53 +/-genotype, 23 (100%) died of malignant tumors within 36 weeks after the last irradiation. Among these, 7 (30%), 15 (65%) and 1 (4%) deaths were caused by lymphoma, mammary adenocarcinoma and sarcoma, respectively. During the period, no death was observed in 26 p53 +/+ animals treated similarly, except for one from non-malignant hemangioma in the ovary at 31 weeks. It should, however, be noted that 1/26 (4%) of surviving p53 +/+ mice developed mammary adenocarcinoma at 39 weeks.
The time and frequency of the deaths from tumors in p53 +/-females exposed to 4 × 0.7 Gy irradiation were illustrated with a histogram in contrast to those in 4 Gy-irradiated p53 +/-females (Fig. 1) . In both irradiation protocols, the onset of lymphomas preceded that of solid tumors. The generation of lymphomas was centered at around 13-20 weeks, whilst most of the mammary tumors arose over 20 weeks with a mode during a period of 21-24 weeks. In the animals exposed to 4 × 0.7 Gy of X-rays, a remarkably increased incidence of mammary tumors was accompanied by a drastic decrease in the frequency of death from thymic lymphoma, when compared with the 4 Gy-irradiated animals: the frequency of sarcomas as well as non-thymic lymphomas remained unchanged. e Not otherwise specified. 
Frequent loss of the p53 wild type allele in tumors of p53 +/-mice
We examined the status of the p53 wild-type allele in the tumors generated in BALB/c-p53 +/-mice. The examined tumors were excised from irradiated or non-irradiated p53 +/-mice. When animals exhibited tumor multiplicity, these tumors were autopsied for testing the p53 genotype. Of 44 primary mammary adenocarcinomas induced by X-irradiation, 44 (100%) exhibited a loss of the wild-type p53 allele in loss of heterozygosity (LOH) or allelic imbalance (AI) at p53 (Table 4) . Representative data of LOH/AI at p53 in these tumors are shown in Fig. 2 . Frequent loss of the p53 wild-type allele was also observed in both radiation-induced thymic lymphomas (22/26, 85%) and sarcomas (5/5, 100%). Likewise, 8/8 (100%) of spontaneous tumors including 3 mammary adenocarcinomas, 4 sarcomas involving bone or soft-tissues and 1 adrenocortical adenoma showed a loss of the wild type allele at p53. In contrast, lymphomas of non-thymic type induced by radiation and those generated spontaneously showed lower LOH frequencies of 3/ 10 (30%) and 2/6 (33%), giving P values smaller than 0.003 and 0.023 (Fisher's exact probability), respectively, as compared to thymic lymphomas.
DISCUSSION
In the present study, we showed that 4 × 0.7 Gy of fractionated X-irradiation induced a high frequency of mammary adenocarcinomas within 36 weeks in p53 +/-female mice with the BALB/ c background. In these animals, a drastic increase in the incidence of mammary tumors occurred without a substantial extension of latency compared to 4 Gy-irradiated p53 +/-animals. In compensation, a profound decrease in the frequency of lymphomas, particularly the thymic type, was observed in 4 × 0.7 Gyirradiated animals. These results suggested that the manifestation of potential mammary tumors induced by radiation in p53 +/-mice was interrupted with frequent death of animals from thymic lymphomas of early onset.
It has recently been reported that BALB/c mice bearing the p53deficient allele are predisposed toward the development of mammary tumors, and that 5 Gy of radiation can induce adenocarcinomas with a considerable frequency. 10, 11) As shown by our data together with these studies, however, a substantial rate of p53 +/-animals exposed to 4-5 Gy of X-irradiation died of lymphomas. Although extensive studies so far reported indicate that fractionated irradiation of approximately 6-7 Gy of X-rays is extremely effective in the induction of thymic lymphomas in susceptible strains of mice, 1, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] our results suggested that this irradiation protocol was also useful for the effective induction of mammary tumors in mice bearing the p53 deficient allele if the X-ray dose applied was properly smaller than 4 Gy. This was further supported by the results that 4 Gy of irradiation was also lymphomagenic to p53 +/+ animals, while 4 × 0.7 Gy-irradiation was not. Since we have not tested the effect of varying X-ray doses applied to animals of various age with different irradiation protocols on tumor spectrum, the optimal irradiation conditions for the induction of mammary tumors remain to be defined.
The rat has frequently been used to study radiation-induced mammary tumors. However, predominant types of mammary tumors in irradiated rats are non-malignant adenomas, such as fibroadenomas. 15) In contrast, most, if not all, of the mammary tumors induced by radiation in BALB/c mice bearing the p53 deficient allele were malignant adenocarcinomas, as shown by our present study together with other studies. 10, 11) Additionally, the availability of the mouse draft sequence is a great advantage to identify candidate genes for diseases following genetic analysis. Therefore, our experimental system using the BALB/c-p53 +/-mouse might be useful for the analysis of mammary tumor susceptibility, which is presently underway.
In our study, a frequent loss of the p53 wild-type allele in LOH was detected in thymic lymphomas induced in p53 +/-mice by ionizing radiation, consistent with reports so far published. 16, 17) In solid tumors, including mammary tumors as well as various types of sarcomas, whether generated spontaneously or induced by radiation, loss of the p53 wild type allele, or occasionally, allelic imbalance (AI) at p53, was detected with a frequency of 100%. These results are also concordant with other reports. 10, 11) In contrast, a loss of the p53 wild-type allele was detected only in approximately one-third of nonthymic lymphomas. An infrequent loss of the p53 wild-type allele in tumors generated in aged p53 +/-mice with the mixed C57BL/6 and 129/Sv background, where the primary type of tumor is lymphoma, has been reported as a proof of a haplo-insufficient effect of p53 on tumorigenesis. 18) Thus, loss of the p53 wild type allele may not be a critical event for the formation of nonthymic lymphomas in p53 +/-animals, but crucial for the development of solid tumors as well as radiation-induced thymic lymphomas.
LOH has been studied to explore tumor suppressors in radiation-induced lymphomas in mice. [19] [20] [21] [22] [23] Our experimental system using p53 +/-animals could also be useful for probing LOH in radiation-induced mammary tumors. However, germline p53 deficiency possibly activates uncommon pathways for tumorigenesis after radiation, as suggested by LOH studies in radiationinduced thymic lymphomas. 21, 23) Actually, in mice p53 mutations are rare in chemically induced mammary tumors as well as radiation-induced lymphomas, 24, 25) whereas p53 mutations are implicated in approximately half of the human sporadic tumors, including mammary neoplasms.
26) It would be of interest to analyze whether the LOH pattern is altered by the p53 status in mammary tumors induced by radiation.
